Why Vertex Pharmaceuticals Is the Best Biotech Stock to Buy in August

Why Vertex Pharmaceuticals Is the Best Biotech Stock to Buy in August

One biotech that has been rapidly gaining traction in treating CF is Vertex Pharmaceuticals (NASDAQ: VRTX) and its drug Trikafta. At the same time, the company's shares have returned 24% year to date. Trikafta is now the locomotive leading Vertex Pharmaceuticals's revenue to record levels.